Multiple Autoantigen Binding Capabilities of Mouse Monoclonal Antibodies Selected for Rheumatoid Factor Activity

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1984 May 1

PMID 6371180

Citations 25

Authors

R L Rubin

R S Balderas

E M Tan

F J Dixon

A N Theofilopoulos

Affiliations

Soon will be listed here.

Abstract

We report that approximately 1/4 of monoclonal rheumatoid factors produced by hybridomas derived from fusions of spleen cells from MRL/lpr/lpr mice with systemic lupus erythematosus (SLE) and arthritis exhibited multiple reactivities with other autoantigens, including dDNA , histones, and/or cytoskeletal-cytoplasmic elements. The patterns of reactivities of most of these clones differed, indicating that each had a separate B cell ancestor. Studies with eluted antibodies demonstrated that a single species of antibody molecules was responsible for the observed multiple reactivities. Inhibition experiments suggested that an antibody combining site may be large enough to accommodate dissimilar epitopes. These findings may provide further insights into the generation and extent of antibody diversity as well as the etiopathogenesis of systemic autoimmune diseases.

Citing Articles

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.

Verkoczy L, Chen Y, Bouton-Verville H, Zhang J, Diaz M, Hutchinson J J Immunol. 2011; 187(7):3785-97.

PMID: 21908739 PMC: 3192533. DOI: 10.4049/jimmunol.1101633.

Effect of circulating immune complexes on the binding of rheumatoid factor to histones.

Gussin H, Russo K, Teodorescu M Ann Rheum Dis. 2000; 59(5):351-8.

PMID: 10784517 PMC: 1753124. DOI: 10.1136/ard.59.5.351.

Human monoclonal rheumatoid factors: incidence of cross-reactions with tissue components and correlation with VH gene usage.

Thorpe S, Borretzen M, Bailey S, Randen I, Natvig J, Thompson K Immunology. 1994; 83(1):114-21.

PMID: 7821955 PMC: 1415009.

An idiotypic complementarity between rheumatoid factor and anti-peptidoglycan antibodies?.

Johnson P, Phua K, Evans H Clin Exp Immunol. 1985; 61(2):373-8.

PMID: 3930111 PMC: 1577307.

Human monoclonal antibodies from patients with rheumatoid arthritis: cross reactions against cellular constituents.

Haskard D, Gul V, Morgan A, Kataaha P, Staines N, Archer J Clin Exp Immunol. 1985; 61(3):496-502.

PMID: 3907900 PMC: 1577268.

References

Bohm E, Strickland W, Strickland M, Thwaits B, van der Westhuizen D, VON HOLT C . Purification of the five main calf thymus histone fractions by gel exclusion chromatography. FEBS Lett. 1973; 34(2):217-21. DOI: 10.1016/0014-5793(73)80797-5. View

Richards F, Konigsberg W, Rosenstein R, VARGA J . On the specificity of antibodies. Science. 1975; 187(4172):130-7. DOI: 10.1126/science.46122. View

Hannestad K, Johannessen A . Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei. Scand J Immunol. 1976; 5(5):541-7. DOI: 10.1111/j.1365-3083.1976.tb00309.x. View

Cameron D, Erlanger B . Evidence for multispecificity of antibody molecules. Nature. 1977; 268(5622):763-5. DOI: 10.1038/268763a0. View

Gottlieb A, Engelhard M, KUNKEL H, TANIGAKI N, Pressman D . A cross-reaction between beta2-microglobulin and kappa-light chains. J Immunol. 1977; 119(6):2001-4. View

Hannestad K, Stollar B . Certain rheumatoid factors react with nucleosomes. Nature. 1978; 275(5681):671-3. DOI: 10.1038/275671a0. View

Johnson P . IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: apparent 'masking' in original serum. Scand J Immunol. 1979; 9(5):461-6. DOI: 10.1111/j.1365-3083.1979.tb03068.x. View

Izui S, Eisenberg R . Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. Clin Immunol Immunopathol. 1980; 15(3):536-51. DOI: 10.1016/0090-1229(80)90065-3. View

Aitcheson C, Peebles C, Joslin F, Tan E . Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen. Arthritis Rheum. 1980; 23(5):528-38. DOI: 10.1002/art.1780230503. View

10.

Agnello V, Arbetter A, Ibanez de Kasep G, Powell R, Tan E, Joslin F . Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med. 1980; 151(6):1514-27. PMC: 2185879. DOI: 10.1084/jem.151.6.1514. View

11.

Cunliffe D, Cox K . IgM-autoantibodies against isologous erythrocytes also react with isologous IgG(Fc). Nature. 1980; 286(5774):720-2. DOI: 10.1038/286720a0. View

12.

Lane D, Hoeffler W . SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature. 1980; 288(5787):167-70. DOI: 10.1038/288167a0. View

13.

Andrzejewski Jr C, Rauch J, Lafer E, Stollar B, Schwartz R . Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol. 1981; 126(1):226-31. View

14.

JOHNSON G, Carvalho A, HOLBOROW E, Goddard D, Russell G . Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis. 1981; 40(3):263-6. PMC: 1000759. DOI: 10.1136/ard.40.3.263. View

15.

Lafer E, Rauch J, Andrzejewski Jr C, Mudd D, Furie B, Schwartz R . Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med. 1981; 153(4):897-909. PMC: 2186121. DOI: 10.1084/jem.153.4.897. View

16.

Pillemer E, Weissman I . A monoclonal antibody that detects a V kappa-TEPC15 idiotypic determinant cross-reactive with a Thy-1 determinant. J Exp Med. 1981; 153(5):1068-79. PMC: 2186160. DOI: 10.1084/jem.153.5.1068. View

17.

DULBECCO R, Unger M, Bologna M, Battifora H, Syka P, Okada S . Cross-reactivity between Thy-1 and a component of intermediate filaments demonstrated using a monoclonal antibody. Nature. 1981; 292(5825):772-4. DOI: 10.1038/292772a0. View

18.

Stollar B . The antigenic potential and specificity of nucleic acids, nucleoproteins, and their modified derivatives. Arthritis Rheum. 1981; 24(8):1010-8. DOI: 10.1002/art.1780240806. View

19.

Senecal J, Rothfield N, Oliver J . Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest. 1982; 69(3):716-21. PMC: 371030. DOI: 10.1172/jci110500. View

20.

Lane D, KOPROWSKI H . Molecular recognition and the future of monoclonal antibodies. Nature. 1982; 296(5854):200-2. DOI: 10.1038/296200a0. View